Natalizumab (Tysabri) for multiple sclerosis: AAN guideline and recommendations

The American Academy of Neurology (AAN) published via the National Guideline Clearinghouse a set of recommendations for the use of the monoclonal antibody Natalizumab (Tysabri) for multiple sclerosis: MAJOR RECOMMENDATIONS Definitions of the strength of the recommendations (A, B, C, U) and classification of the evidence (Class I through Class IV) are provided at the […]

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos